Dr. Du is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3009 N Ballas Rd
Ste 100B
Saint Louis, MO 63131Phone+1 314-983-4095Fax+1 314-432-7317- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Rheumatology, 2002 - 2004
Mercy Hospital (St Louis)Residency, Internal Medicine, 1999 - 2002
Washington University in St. LouisResearch Associate, Rheumatology, 1998 - 1999
National Institutes of Health Clinical CenterRheumatology, 1991 - 1995
West China University of Medical SciencesClass of 1986
Certifications & Licensure
MO State Medical License 2004 - 2025
IL State Medical License 2004 - 2005
PA State Medical License 2002 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Five Star Excellence Award BJC Medical Group, 2013
- Clinical Fellow Award University of Pennsylvania, 2003
- Honors Fellow in Rheumatology Award Ortho-McNeil, 2003
- Join now to see all
Publications & Presentations
PubMed
- The ER Membrane Adaptor ERAdP Senses the Bacterial Second Messenger C-di-AMP and Initiates Anti-Bacterial ImmunityYing Du, MD> ;Nature.
- 61 citationsBlockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2.Akihiko Nishikimi, Takehito Uruno, Xuefeng Duan, Qinhong Cao, Yuji Okamura, Takashi Saitoh, Nae Saito, Shunsuke Sakaoka, Yao Du, Atsushi Suenaga, Mutsuko Kukimoto-Niin...> ;Chemistry & Biology. 2012 Apr 20
- 7 citationsLocalization of the gene responsible for the op (osteopetrotic) defect in rats on chromosome 10Elaine F. Remmers, Y Du, Yan-Ping Ding, Shigeru Kotake, Lynn Ge, Hongbin Zha, Ellen Goldmuntz, C Hansen, Ronald L. Wilder> ;Journal of Bone and Mineral Research. 2010 Feb 24
- Join now to see all
Press Mentions
- Efficacy and Safety of PEGylated Exenatide Injection (PB-119) in Treatment-Naive Type 2 Diabetes Mellitus Patients: A Phase II Randomised, Double-Blind, Parallel, Placebo-Controlled StudyMarch 9th, 2021
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin), Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
